GENETETHER THERAPEUTICS INC.

Other languages GeneTether Therapeutics Inc.

Equities

GTTX

CA37187D1087

Market Closed - Canadian Securities Exchange Other stock markets 08:15:02 21/05/2024 pm IST			5-day change	1st Jan Change
0.025 ^CAD	-54.55%		0.00%	-37.50%

30/03	5,174,558 Common Shares of GeneTether Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	CI
29/03	GeneTether Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GeneTether Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
GeneTether Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
GeneTether Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26/23/26
GeneTether Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26
GeneTether Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28
GeneTether Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	26/22/26
GeneTether Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25
GeneTether Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27
GeneTether Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	29/22/29
GeneTether Therapeutics Inc. has completed an IPO.	29/22/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer